JP2013519653A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013519653A5 JP2013519653A5 JP2012552401A JP2012552401A JP2013519653A5 JP 2013519653 A5 JP2013519653 A5 JP 2013519653A5 JP 2012552401 A JP2012552401 A JP 2012552401A JP 2012552401 A JP2012552401 A JP 2012552401A JP 2013519653 A5 JP2013519653 A5 JP 2013519653A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- scb
- derivatives
- gtx
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229940125794 sodium channel blocker Drugs 0.000 claims description 15
- 239000003195 sodium channel blocking agent Substances 0.000 claims description 15
- RPQXVSUAYFXFJA-HGRQIUPRSA-N saxitoxin Chemical compound NC(=O)OC[C@@H]1N=C(N)N2CCC(O)(O)[C@@]22N=C(N)N[C@@H]12 RPQXVSUAYFXFJA-HGRQIUPRSA-N 0.000 claims description 7
- RPQXVSUAYFXFJA-UHFFFAOYSA-N saxitoxin hydrate Natural products NC(=O)OCC1N=C(N)N2CCC(O)(O)C22NC(N)=NC12 RPQXVSUAYFXFJA-UHFFFAOYSA-N 0.000 claims description 6
- CFMYXEVWODSLAX-QOZOJKKESA-N tetrodotoxin Chemical compound O([C@@]([C@H]1O)(O)O[C@H]2[C@@]3(O)CO)[C@H]3[C@@H](O)[C@]11[C@H]2[C@@H](O)N=C(N)N1 CFMYXEVWODSLAX-QOZOJKKESA-N 0.000 claims description 5
- 229950010357 tetrodotoxin Drugs 0.000 claims description 5
- CFMYXEVWODSLAX-UHFFFAOYSA-N tetrodotoxin Natural products C12C(O)NC(=N)NC2(C2O)C(O)C3C(CO)(O)C1OC2(O)O3 CFMYXEVWODSLAX-UHFFFAOYSA-N 0.000 claims description 5
- 230000035945 sensitivity Effects 0.000 claims description 4
- 241000124008 Mammalia Species 0.000 claims description 3
- CDJDGQRYHDBSKC-UHFFFAOYSA-N 2,3,4,5,6,7,8,9-octahydro-1h-purine Chemical compound C1NCNC2NCNC21 CDJDGQRYHDBSKC-UHFFFAOYSA-N 0.000 claims description 2
- 230000035807 sensation Effects 0.000 claims description 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 22
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims 2
- 208000035154 Hyperesthesia Diseases 0.000 claims 2
- 230000000202 analgesic effect Effects 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 230000000699 topical effect Effects 0.000 claims 2
- LEBVLXFERQHONN-UHFFFAOYSA-N 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide Chemical compound CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-UHFFFAOYSA-N 0.000 claims 1
- 208000001387 Causalgia Diseases 0.000 claims 1
- 208000023890 Complex Regional Pain Syndromes Diseases 0.000 claims 1
- 208000004454 Hyperalgesia Diseases 0.000 claims 1
- 206010020751 Hypersensitivity Diseases 0.000 claims 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 claims 1
- PPEKGEBBBBNZKS-UHFFFAOYSA-N Neosaxitoxin Natural products N=C1N(O)C(COC(=O)N)C2N=C(N)NC22C(O)(O)CCN21 PPEKGEBBBBNZKS-UHFFFAOYSA-N 0.000 claims 1
- 206010029240 Neuritis Diseases 0.000 claims 1
- 241000687919 Rodinia Species 0.000 claims 1
- 208000036142 Viral infection Diseases 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 208000026935 allergic disease Diseases 0.000 claims 1
- 229960003150 bupivacaine Drugs 0.000 claims 1
- 208000014439 complex regional pain syndrome type 2 Diseases 0.000 claims 1
- 239000006071 cream Substances 0.000 claims 1
- 239000007933 dermal patch Substances 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- PJMPHNIQZUBGLI-UHFFFAOYSA-N fentanyl Chemical compound C=1C=CC=CC=1N(C(=O)CC)C(CC1)CCN1CCC1=CC=CC=C1 PJMPHNIQZUBGLI-UHFFFAOYSA-N 0.000 claims 1
- 229960002428 fentanyl Drugs 0.000 claims 1
- 230000009610 hypersensitivity Effects 0.000 claims 1
- 229960004194 lidocaine Drugs 0.000 claims 1
- 239000002502 liposome Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000004530 micro-emulsion Substances 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- PPEKGEBBBBNZKS-HGRQIUPRSA-N neosaxitoxin Chemical group N=C1N(O)[C@@H](COC(=O)N)[C@@H]2NC(=N)N[C@@]22C(O)(O)CCN21 PPEKGEBBBBNZKS-HGRQIUPRSA-N 0.000 claims 1
- 210000005036 nerve Anatomy 0.000 claims 1
- 208000004296 neuralgia Diseases 0.000 claims 1
- 201000001119 neuropathy Diseases 0.000 claims 1
- 230000007823 neuropathy Effects 0.000 claims 1
- 230000007935 neutral effect Effects 0.000 claims 1
- 239000002674 ointment Substances 0.000 claims 1
- 229960005489 paracetamol Drugs 0.000 claims 1
- 230000001575 pathological effect Effects 0.000 claims 1
- 208000033808 peripheral neuropathy Diseases 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000012453 solvate Chemical class 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 230000009885 systemic effect Effects 0.000 claims 1
- 238000011200 topical administration Methods 0.000 claims 1
- 230000009385 viral infection Effects 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10153234.9 | 2010-02-10 | ||
| EP10153234 | 2010-02-10 | ||
| US31290310P | 2010-03-11 | 2010-03-11 | |
| US61/312,903 | 2010-03-11 | ||
| PCT/EP2011/051992 WO2011098539A1 (en) | 2010-02-10 | 2011-02-10 | Treatment of loss of sense of touch with saxitoxin derivatives |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016217143A Division JP2017081920A (ja) | 2010-02-10 | 2016-11-07 | サキシトキシン誘導体での触覚の喪失の処置 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013519653A JP2013519653A (ja) | 2013-05-30 |
| JP2013519653A5 true JP2013519653A5 (OSRAM) | 2014-03-13 |
| JP6112867B2 JP6112867B2 (ja) | 2017-04-12 |
Family
ID=43828310
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012552401A Active JP6112867B2 (ja) | 2010-02-10 | 2011-02-10 | サキシトキシン誘導体での触覚の喪失の処置 |
| JP2016217143A Pending JP2017081920A (ja) | 2010-02-10 | 2016-11-07 | サキシトキシン誘導体での触覚の喪失の処置 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016217143A Pending JP2017081920A (ja) | 2010-02-10 | 2016-11-07 | サキシトキシン誘導体での触覚の喪失の処置 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US9107925B2 (OSRAM) |
| EP (1) | EP2533785B1 (OSRAM) |
| JP (2) | JP6112867B2 (OSRAM) |
| CN (1) | CN102811722A (OSRAM) |
| ES (1) | ES2484315T3 (OSRAM) |
| WO (1) | WO2011098539A1 (OSRAM) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10512644B2 (en) | 2007-03-12 | 2019-12-24 | Inheris Pharmaceuticals, Inc. | Oligomer-opioid agonist conjugates |
| US8173666B2 (en) | 2007-03-12 | 2012-05-08 | Nektar Therapeutics | Oligomer-opioid agonist conjugates |
| EP2533785B1 (en) * | 2010-02-10 | 2014-04-23 | Phytotox Limited | Treatment of loss of sense of touch with saxitoxin derivatives |
| EP2638908A1 (en) * | 2012-03-16 | 2013-09-18 | Phytotox SpA | Paralytic Shellfish Poison |
| KR20210062693A (ko) * | 2013-03-15 | 2021-05-31 | 더 칠드런스 메디칼 센터 코포레이션 | 지속성 국소 마취용 네오삭시톡신 조합 제형 |
| EP3129381B1 (en) * | 2014-04-09 | 2020-11-04 | Siteone Therapeutics Inc. | 10',11'-modified saxitoxins useful for the treatment of pain |
| JP2018534270A (ja) * | 2015-09-30 | 2018-11-22 | サイトワン セラピューティクス， インコーポレイテッド | 疼痛の治療のための１１，１３−修飾サキシトキシン |
| GB201602576D0 (en) | 2016-02-12 | 2016-03-30 | Bergen Teknologioverforing As | Process |
| WO2018183781A1 (en) | 2017-03-29 | 2018-10-04 | Siteone Therapeutics, Inc. | 11,13-modified saxitoxins for the treatment of pain |
| CN110914276A (zh) * | 2017-03-29 | 2020-03-24 | 赛特温治疗公司 | 用于治疗疼痛的11,13-修饰的石房蛤毒素类化合物 |
| US12162886B2 (en) | 2018-10-03 | 2024-12-10 | Siteone Therapeutics, Inc. | 11,13-modified saxitoxins for the treatment of pain |
| BR112023002659A2 (pt) * | 2020-08-14 | 2023-05-02 | Siteone Therapeutics Inc | Inibidores de cetona não hidratados de nav1.7 para o tratamento da dor |
| WO2022112887A1 (en) * | 2020-11-25 | 2022-06-02 | Algenis | Method of treating acute nociceptive pain in mammals |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1284536C (zh) * | 2000-09-18 | 2006-11-15 | 威克斯医药有限公司 | 河豚毒素或蛤蚌毒素及其类似物在制备用于全身镇痛的镇痛药中的应用 |
| US20030100574A1 (en) | 2001-11-15 | 2003-05-29 | Wilson Nestor Antonio Lagos | Use and application of a pharmaceutical composition containing a mixture of natural-origin heterocyclical guanidine, for cosmetology, wound healing, focal dystonia and muscular spasm-related clinical pathologies |
| US20080021051A1 (en) | 2004-05-07 | 2008-01-24 | Phytotox Limited | Phycotoxins and Uses Thereof |
| CA2607206C (en) | 2004-05-07 | 2016-06-14 | Phytotox Limited | Transdermal administration of phycotoxins |
| CA2581128A1 (en) | 2004-09-21 | 2006-03-30 | Laboratorios Del Dr. Esteve, S.A. | Tetrodotoxin and its derivatives for the treatment of central-nervously derived neuropathic pain |
| CA2581083A1 (en) | 2004-09-22 | 2006-03-30 | Helmut Henrich Buschmann | Tetrodotoxin and its derivatives for the treatment of peripheral-nervously derived neuropathic pain |
| CN101563079B (zh) | 2006-03-27 | 2012-12-05 | 威克斯药业有限公司 | 钠通道阻滞剂在制备治疗由于化疗而产生的神经病理性疼痛的药物中的用途 |
| EP2533785B1 (en) * | 2010-02-10 | 2014-04-23 | Phytotox Limited | Treatment of loss of sense of touch with saxitoxin derivatives |
-
2011
- 2011-02-10 EP EP11707610.9A patent/EP2533785B1/en active Active
- 2011-02-10 ES ES11707610.9T patent/ES2484315T3/es active Active
- 2011-02-10 JP JP2012552401A patent/JP6112867B2/ja active Active
- 2011-02-10 US US13/575,229 patent/US9107925B2/en active Active
- 2011-02-10 CN CN2011800149701A patent/CN102811722A/zh active Pending
- 2011-02-10 WO PCT/EP2011/051992 patent/WO2011098539A1/en not_active Ceased
-
2015
- 2015-07-08 US US14/794,428 patent/US20160000793A1/en not_active Abandoned
-
2016
- 2016-11-07 JP JP2016217143A patent/JP2017081920A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013519653A5 (OSRAM) | ||
| MY202837A (en) | Lipids for lipid nanoparticle delivery of active agents | |
| TN2013000293A1 (en) | Derivatives of azaindazole or diazaindazole type as medicament | |
| MX2022013054A (es) | Derivados de imidazolidinona y uso medico de los mismos. | |
| EA201101671A1 (ru) | Замещенные производные аминопропионовой кислоты в качестве ингибиторов неприлизина | |
| JP2013542247A5 (OSRAM) | ||
| RU2013142448A (ru) | Новые сульфонаминохинолиновые антагонисты гепсидина | |
| KR20150013527A (ko) | 항염증 활성과 접합된 증진된 항인플루엔자제 | |
| JP2009504763A5 (OSRAM) | ||
| JP2013508279A5 (OSRAM) | ||
| JP2015530382A5 (OSRAM) | ||
| RU2011146005A (ru) | Композиции для лечения воспаления и способы лечения воспаления | |
| JP2013522229A5 (OSRAM) | ||
| ES2698363T3 (es) | Composiciones de oxprenolol para tratar el cáncer | |
| BR112013026257A2 (pt) | derivados de glicosídeo e usos dos mesmos para o tratamento de diabetes | |
| JP2013518036A5 (OSRAM) | ||
| EP3791897A1 (en) | Hsp90 inhibitor drug conjugates | |
| JP2017513824A5 (OSRAM) | ||
| MY150682A (en) | Method for using vasopressin antagonist with anthracycline chemotherapy agents to reduce cardiotoxicity and/or improve survival | |
| AR075626A1 (es) | Metodos para administrar (4ar,10ar)-1-n- propil-1,2,3,4,4a,5,10,10a- octahidro -benzo (g) quinolin-6,7-diol y sus composiciones farmaceuticas. uso. | |
| BR112013026361A2 (pt) | derivados de glicosídeo e usos dos mesmos | |
| MX2024014315A (es) | Compuestos amido heteroaromaticos utiles en el tratamiento de enfermedades hepaticas | |
| NO20082181L (no) | Formuleringer av Fispemifen | |
| EP4591940A3 (en) | Deoxy- cytidine derivatives for use in cancer therapies | |
| EP2772481A8 (en) | Novel compound as kcnq potassium channel agonist, preparation method therefor and use thereof |